Related Experiment Video
Updated: May 7, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Physician-prescribed medication use by the Finnish Paralympic and Olympic athletes
Anni Aavikko1, Ilkka Helenius, Tommi Vasankari
1*The Paavo Nurmi Centre Sports & Exercise Medical Unit, Department of Physiology, University of Turku, Turku, Finland; †Department of Pediatric Orthopedic Surgery, Turku University Central Hospital, Turku, Finland; ‡The UKK Institute for Health Promotion Research, Tampere, Finland; §Division of Welfare and Health Promotion, Department of Lifestyle and Participation, National Institute for Health and Welfare, Helsinki, Finland; and ¶The Finnish Olympic Committee, Helsinki, Finland.
Objective:
Data about medication use by Paralympic athletes (PAs) are limited and no data concerning medication use outside Paralympics exist. The objective of the current study was to compare the use of physician-prescribed medication in PAs and Olympic athletes (OAs).
Design:
A cross-sectional comparative study.
Setting:
Finnish PAs and OAs receiving financial support from the Finnish Olympic and Paralympic committee in 2006 and 2009, respectively.
Participants:
A total of 92 PAs (response rate, 75.0%; 92 of 123) and 372 OAs (response rate, 91.9%; 372 of 405) participated.
Assessment Of Risk Factors:
Age, sex, and type of athlete (PA vs OA) were included as independent covariates in the logistic regression model analysis.
Main Outcome Measures:
The use of physician-prescribed medication among athletes during the previous 7 days and 12 months.
Results:
Among the PAs, the use of physician-prescribed medicines (48.9% vs 33.3%; adjusted odds ratio, 1.99; 95% confidence interval, 1.13-3.51), painkillers (2.61; 1.18-5.78), oral antibiotics (4.10; 1.30-12.87), and anti-epileptic medicines (37.09; 5.92-232.31) were more common than among the OAs during the previous 7 days. Paralympic athletes had used significantly less asthma medicines than the OAs during the previous 7 days (4.3% vs 11.0%; adjusted odds ratio, 0.30; 95% confidence interval, 0.10-0.96).
Conclusions:
The use of any physician-prescribed medicines, especially those to treat chronic diseases, seems to be more common among the PAs than the OAs. Paralympic athletes use significantly less asthma medicines than OAs.
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Inhaled Medications
Pharmaceutical Poisoning: Potential Scenarios
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Drug Therapy
Antianxiety Medications
